Akari Therapeutics Plc - ADR

NASDAQ:AKTX   1:49:41 PM EDT
1.33
-0.04 (-2.92%)
Earnings Announcements

Akari Therapeutics Reports Third Quarter 2021 Financial Results And Highlights Recent Clinical Progress

Published: 12/03/2021 13:02 GMT
Akari Therapeutics Plc - ADR (AKTX) - Akari Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Clinical Progress.
Akari Therapeutics Plc - Qtrly Loss per Share $0.00.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be $0.00

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.